The Center to Reduce Cancer Health Disparities (CRCHD) is central to NCI's efforts to reduce the unequal burden of cancer in our society and train the next generation of competitive researchers in cancer and cancer health disparities research. CRCHD initiates, integrates, and engages in collaborative research studies with NCI divisions and National Institutes of Health (NIH) Institutes and Centers to promote research and training in cancer health disparities research and to identify new and innovative scientific opportunities to improve cancer outcomes in communities experiencing an excess burden of cancer.
In January 2012, Dr. Harold Varmus, NCI director, underscored his commitment to cancer genomics research by announcing the formation of the Center for Cancer Genomics. This new center integrates much of the cancer genomics efforts at NCI, including the Office of Cancer Genomics (OCG) and The Cancer Genome Atlas (TCGA)
The Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute (NCI), and the only one in the Washington, DC, area.
The GW Medical Center's Cancer Institute (GWCI) takes a comprehensive approach to a complex disease. In connection with the GWU Hospital and the GW Medical Faculty Associates, the Institute provides for collaboration in the study, diagnosis and treatment of cancer. Our mission is to provide a confluence of groundbreaking biomedical and clinical research, high quality educational programs, outstanding patient care to the entire Metropolitan Washington area, and effective outreach for our community.
The unique aspect of Howard University Cancer Center (HUCC) is its natural ability and strength to address cancer disparities with an emphasis on those cancers that disproportionately impact African-Americans, in particular. The mission of HUCC is to reduce the burden of cancer through research, education, and service, with emphasis on the unique ethnic and cultural aspects of minority and underserved populations.
The Johns Hopkins Sidney Kimmel Cancer Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control. Since its opening in 1973, our Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to treat it. The strength of our research and treatment programs was recognized early on by the National Cancer Institute, becoming one of the first to earn comprehensive cancer center status and recognition as a "Center of Excellence."